Skip to content
Late-StageResearch compoundModerate evidence

Bemethyl

Soviet-developed anti-fatigue compound; a medicine in Russia, not approved in the EU or the US.

NootropicStimulantActoprotectorStimulantAnti-fatigueAnti-fatiguenoo.affects.mitochondrialSerotonin
Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Pharmacology

ClassStimulant · Anti-fatigue
Primary targetGluconeogenesis and protein synthesis enhancement (actoprotector)
Targets4 receptor targets
Half-lifeHuman pharmacokinetic data are limited; the effect accumulates over days with repeated dosing
OnsetA single dose acts within hours, but the full effect builds over several days of repeated dosing
EvidenceModerate evidence
Affected systemsAnti-fatiguenoo.affects.mitochondrialSerotonin

Contents

DETAILED OVERVIEW

What is Bemethyl?

Bemethyl (also called bemitil or Metaprot) is a compound developed in the Soviet Union, a so-called actoprotector, meaning a substance that helps the body cope with strain. It is registered as a medicine in Russia and a few former Soviet states, but it is not approved in the EU, the United States or Hungary.

Unlike classic stimulants, it does not work by raising oxygen consumption or heat production. Research suggests it stimulates enzymes involved in producing energy sources and building protein, and helps cells cope with a lack of oxygen. Its effect builds up gradually with repeated use. Most of the evidence comes from Russian-language studies, and there is little data on long-term safety. Restlessness, sleep problems, stomach upset and a slight rise in pulse or blood pressure may occur; its safety in pregnancy and breastfeeding has not been established. A doping-control method for detecting it has already been developed, so anti-doping rules also matter in competitive sport.

Mechanism

Actoprotector (gluconeogenesis + protein synthesis)

Evidence

Moderate, mostly Russian human and animal data

Legal status

Medicine in Russia, unapproved in the West

Receptor profile

  • Gluconeogenesis / protein and enzyme synthesis (RNA induction)Moderate
  • Mitochondrial efficiency / antihypoxant actionModerate
  • Brainstem monoaminergic (serotonergic) neuron modulationWeak
  • Antioxidant defenseWeak

Safety

Side effects, stop signs, contraindications

Side effects · 5

  • Overstimulation, restlessness or sleep disruption, especially with late or high-dose intake
  • Stomach upset, nausea, occasional headache
  • Mild increase in heart rate or blood pressure, as with other stimulants
  • Irritability or anxiety in sensitive individuals
  • Long-term safety data are limited and come mostly from Russian-language studies

Contraindications · 4

  • Pregnancy and breastfeeding: safety not established, avoid
  • Uncontrolled hypertension, arrhythmia or severe cardiovascular disease
  • Anxiety disorders, panic disorder: the stimulant effect may worsen them
  • Not an approved medicine in Western countries; competitive athletes should check current anti-doping rules

Related Nootropics

Same therapeutic category

Studies

Related research and clinical findings

FAQ

FAQ

Bemethyl was originally developed in the Soviet Union as an anti-fatigue aid for the military and sport: the idea is to help the body handle more physical strain, recover faster after tough exertion, and adapt better to low-oxygen conditions like high altitude. Its effect is described as cumulative, meaning it tends to build up with repeated use.

Telegram

Have a question about Bemethyl?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeNootropic
FormulaC9H11BrN2S
UpdatedOctober 13, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 13, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.